Replies to post #269741 on Avid Bioservices Inc (CDMO)

[north40000]

Just like BioBS2012 asked/said---it sounds familiar/similar.

"Just in case you think only PPHM management talks a certain way. Here are some comments extracted from BMY management. Notice anything similar?"
#269728

[vinmantoo]

Yea they weren't confusing. They said Opdivo performed generally as expected as did chemotherapy. Opdivo just didn't perform well enough. I guess "generally" as expected is not good enough to beat chemo which performed as expected.

Nothing about a outperforming control arm. Just they are surprised Keytruda did as well as it did.

Right, it was clear that it didn't beat the control enough to merit approval. The comment about Keytruda irrelevant to their trial. In contrast, PPHM tried to spin that Bavi-Doc was successful but they were done in by a supposedly dramatically out-performing control arm.

The outcome is the same for both, neither drug will proceed to FDA approval. The difference is that PPHM either 1) really had the numbers to backup their statement, or 2) they were lying (spinning) in a futile effort to minimize damage from the trial failure. They were being vague to protect themselves from lawsuits. If they really had numbers to support their comments, why have they not stated what the numbers were even 6 months later, and why have they stopped touting that control arm outperforming line (excuse)?